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    The zinc concentration in the male genital organs of rats， dogs and men has been measured
by means of atomic absorption spectrophotometry．
    The infiuence of antiandrogenic hormones to the zinc concentration in the orgaps was’ also
studied． The results obtained are as follows；
    1． As t6 the zinc concentration in the male genital organs of rats， the dorsolateral prostate
showed the highest mean value of 49． 1 mcg／g wet weight， while cauda epidiclymis， caput epididy－
mis， testis， coagulating gland， Ventral prostate and seminal vesicle averaged 27．3， 27．0， 21．2， 19． z
15．3 and 12．9mcg／g wet weight respectively．
    As for the total zinc contents of a pair of organs， the study was performed on a unilateral
organ． The testis revealed the highest mean value oiC 26．2mcg／organ， while dorsolateral prostate，
seminal vesicle， ventral prostate and coag．ulatipg gland averaged 6．6， 2，3， 1．3 and O．9mc g／organ
respectively．
    2． With regard to the zinc concentration in the male genital organs of ・dogs， the prostate
showed the highest mean value of 133．4mcg／g wet weight， although， cauda epididymis， caput
epididymis and testis averaged 19．0， 16．6 and 10．3mcg／g wet weight．
    3． ’The influence of the three kinds of antiandrogenic hormones， diethyl－dihydroxystilbene－
diphosphate （Honvan），17－ev－hydrQxy－lg－norprogesterone caproate （SH 582） and estradiol valerianate
（Proginpn depot） to the zinc concentratiop in the male genital organs of the rats was evaluated．
The concentration decreased significantly in the dorsolateral prostate with the administration of
Honyan in the dorsolateral prostate and the testis with SH 582 and the testis with Proginon depot
compared with those of the normal controls．
   The si’gnificant decrease of total zinc contents of the organs was recognized． in the testis and
in the dorsolateral prostate in all the treated－groups， as well as in almost all the other organs of
the groups．
    4． Likewise， the influence of the three hormones to the zinc concentration in the male genital
organs of the dogs was estimated． The concentration declined significantly in the prostate， in the
testis and in the epididymis with the administration of Honvan and SH 582． The prominent
decline of the concentration iri those given Proginon depot was initially found in the prostate， then
in the testis， and finally ih the epididymis as the dose of the hormone was increased．
    5， In relatiQ“tQ the zinc co皿ce翼tratiQ簸in the呂eロit艮l or慕ans Qf theτロe具exaロ1取ed塁the prQ§一
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tates which were postmortem specimens， marked the highest mean value of 33．6 mc g／g wet weight．
The cadavers were treated with forrnalin and red lead before preservation． The concentrations in
the other organs which were surgically extracted from the patients of prostatic carcinoma， caput
epididymis， cauda epididymis and testis averaged 16．4，1ら．7 and 10．6血cg／g wet weight r6spec－
tively．
   6． Furthermore， the infiuence of．the therapeutic’ dose of Honvan and SH 582 to the zinc
concentration in both the testis and’ the． epididymis of the patients of prostatic carcinoma was ex－
amined． The concentration showed a decreasing tendency， howevet， no statistically significant
difference was proved compared with those’ of the normal controls．
   The significant decrease of the total zinc cQntents of the testis treated with Honvan was confirmed．
   7． The zinc concentration in fertile hurnan seminal plasma averaged 204．5’mcg／g wet weight．
   A study was performed in connegtion with sperm count in sterile patiente， though only a’
group of azoospermia averaged the concentration of 120．2mc g／g wet weight， which denoted a
statistically significant decrease gompared with the normal controls．
   In a similar study relating to sperm motility， onl．y a’group of necrozoospermia showecl the
average of the concentration of 78．3皿cg／g wet weight． The result pointed out a prominent
decrease， but not ．a statistically signifieant．decrease， compared with tbe normql coptrols．
   The zinc concentration in fertile human seminal sediment averaged 266．3mcg／g wet weight．
   No significant relation was found between zinc concentration of sterile seminal sediment and
sperm count or motility． Moreover， the concentration in’sterile seminal sedinient proved no statis－
tical difference from that of the normal controls．
   8． The zinc concentration in sterile human． seminal plasma seemed to increase in proportion
to the increase of total urinary gonadQtropin． No statistical analysis was performed because of the
small number of cases．
緒 言























































 且群 SH 582①50mg週1回，計4回投与，
②100mg週1回，計4回投与．
 皿群 Progin・n dePot①O，5mg週1回，計4回
投与，②1．Omg週1回，計4回投与．
 イヌ
 1群 Honvan①50 mg 1日1回，連続10回投与，
②100mg 1日1回，連続10回投与．
 目性SH 582（1）100 mg週1回，計4回投与，
②200mg週1回，計4回投与．






































         H．実験成績
 D 正常ラット性腺系の各臓器重量（Table 1）




  2mg （ 5）
 10mg （ 5）
SH 582
 50mg （ 5）
 100mg （10）
Proginon depot
 O． 5rng （ 5）






















































         Table 2
Z工NC CONTENT OF丁HE二GENITAL ORGANS OF THE：RAT










21 ．1 680± 4 ．4959
26．9680± 4．0881
27．3400± 5．9427
15 ．2520± 4 ．6274
49 ．rt 240i1 6．6407
19．6520t 6．6226
fi 2．gt 20±2．8514
















Zinc content of organ
 （mcg ．／ ongan）
26．1850±4．9936
       T1 ．31 68 ±1 ．1736
． 6．6412±2．8620
 0．8578 ± O．7322
2．2883士1．0008












         Table 4
ZINC CONTEN丁OF丁HE GENITAL ORGANS OF THE DOG
           Zinc content of o－gan
    Organ 〈mcg ．／g ．wet weight）
  Testis 10．2900± 2．1 234
  Caput epididymis 19．0200± 2．4256
  Cauda epididymis ’16．5500± 1 ．’1182























 1群 Honvan（Table 5）
         Table 5
Z工NO CONTENT OF THE GENITAL ORGANS OF THE RAT
      TREATED WITH HONVAN
 Organ Z inc content of organ （tncg．／g．wet weight）
         Group”2mg．” Group”10mg．”
Testis ・ 17．8333± 3．4544 18．3600t 2．3243
Coput epididymis   18。1200土3．9710 34．320吐11．7376
Cauda epididymis 29．3800t 8．1243 16．7800t 6．1274
Ventnoi prostate 13．4857± 4．a268 32．180D±20．3337
Dorsolateral pro＄tate 42．5000t20．0082 30．3200±12．2985
Coagulating gland n7．0333± 7．0168 24．5500＋一11．6160
SemTnal vesic］e’ a5．9375＋一 5．2578 18．0000t 4．5426






Fig．2．イヌ睾丸 Honvan lOO mg群
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    Fig．4．イヌ睾：丸 Proginon depot 2．5mg群
       （H．E．染色，4×40）
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Fig．1．イヌ睾丸 正常（対照）群
   （H．E．染色，4×40）
Fig，3．イヌ睾：丸 SH 582200 mg群
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   Fig．6．イヌ前立腺Honvan 100 mg群
     （H．E．染色，4x16）
  Fig．8．イヌ前立腺 Proginon depot 2．5mg群
    （H．E．染色，4×16）
   Fig．7．イヌ前立腺 SH 582200 mg群
     （H．E．染色，4×16）
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Tabl’e 6
ZINC CONTENT OF THE GENITAL ORGANS OF THE RAT・
         TREATED WITH SH 582 ．
 Ongan Zinc content of organ （mcg．／g．wet welght）
            Gr・oup飾50mggl邑：
Testis f9．6428±3．3818
Caput epididymis 28 ．4875± 5．rt 605
Cauda epididymis 26 ．6250t 5 2511
Ventral prostate 13．7000t 5．7664
Dorsolateral prdstate 49．6142±20．6439
Coagulating gland 29．2500±13．9B46









（mean with standard deviation）
Table 7
ZIN（⊇CQN↑ENT OF THE GENI丁AL ORGANS OF THE RAT









z． inc content of－organ （mcg．／g．wet weight）
    Group”O．5mg．” Group”a．orng．”
   16．0200± 5．6615 35．2666±14．9312
   a8．8000± 7．7224 32．4000i 7．8396
   35のりO（）O土8．9389． 24．0666土3．9296
   35 ．2000tA 4．9216 105・．2666±16．7061
  38．4000土8．7521  66．700q土2790186
  43．8000t19．0132 40．5000± 4．7000
   15．4SOO± 3．3949 a 6．9333± 6．a 958
    （mean with standard deviation）
Table 8
Z工N（）CONTENT OF THE．G巨NITAL QRGANS OF丁HE RAT







Zinc content of organ （m¢g．／ organ）
Greup”2rng．” Group”IQrng．”
 not recorded al．6420 ±1．2628
0．7057 一一 O ．2851 1 ．1 700 ＋一1 ．01 07
 nDt recorded 3A400 ±1 ．231 9
0．3250±O．1269 O．5575±O．2678
0．988B 1二〇．2188  1．1680土0．6544
（mean with standard deviation）
三差をもって減少した．
















之INO OONTENT OF T日E：GE：N工TAしORGANS OP THE RAT
         「「REATED W工TH．．SH 582
0rgan zinc coAtent of 6rgan （mcg．／ organ）’
             Group瞳「50mg．薗I
Testis ’ 25 ．4925 “一 3．5443
Ventral prostate O．7625 ±O’．5530
Dorsolateral prostate 6．0225 ’． a．9463








（mean wlth standard devlatlon）
Table 10
ZINO CONTE二NT OF：’「HE GE：NITAL ORGANS OF THE RAT







zinc content 6f organ （mcg．／ organ）
Group”O．5mg．”








2 ．9300 ±1 ．A 731
Q．2600ゴニO，0100
 0．4333teA901
（thean with ＄tandard devlation）
 7）処置群ラット性腺系の臓器当り亜鉛量
  1群Honvan（Table 8）


























































ZINC CONTENT OP THE GE：NI丁AL ORGANS OF THE DOG
      TREATED WITH HONVAN
 Organ Zinc content of organ （mcg．／g．wet weight）
        Group”50mg．” Group”100mg．”
Testis 8．5428tO．7979 12．7s57±6．3323
Caput ep；didyrnis 13．0857±5．7145 M．B714十一3．76Bs
Cauda epididymis 9．5333±3．4344 7．6666 t3．2304
































Z：NC CONTENT OF THE GE＝N工TAL ORGANS OF THE DOG
      TREATED WITH SH 582
 0ngan zinc content of organ （mcg．／g．wet weight）
        Group”100mg．” Group”200mg．”
Testis 5．9852±1．5788 t7．02S5±5．7989
Caput epididynnis 12．0800± 1 ．7634 20 ．2833 ± 7．7462
Cauda epididymis 8．62B5＋一1．9099 a4．1166±3．7280
Prostate 39．7000M5．1339 12．1750±5．S593
        （mean with standartd deviation）
               Table 13
ZINC CONTENT OF THE GE：NITAしORGAN50F THE DOG TREATED W工TH PROG工NQN DEPOT
organ zinc content of organ （mcg．／g．wet weight）
        Group”’1．Omg．” Group”2．smg．” Group”5．Omg．”
Test［s 13．4285±4．3803 ls．3000±1．6gB2 6．5250±1．9885
Caput epididymis l s．6714±5．6947 rt 6．2200 t 3．6140 6．9750 t rt ．8799
Cauda epididymis 18．2200±s．s473 16．1000±1．9924 6．2555 ＋一1．0563
Prostate 22 ．0000±s ．4 92S 19 ．2250 ＋一 3．8906 8．7333 ±2A 959



















 HQnvan， SH 582， Proginon depotのほとんどすべ
ての処置群で重量は減少したが，その減少率は背側部
前立腺ではHonvan 10 mg群で48．6％， S H 58250
mg群で34．9％， Proginon depot 1．Omg群で91．8
ZINC CON丁E閥T OI： THE GENITAL ORGANS OFτ｝｛E



















wgt 儀Pαt ca瞭 》er劇 ＆湘1















Honvan 100 mg群， S H 582100 mg群，200 mg群，






が14．3mcg／9， Proginon depot O．5mg群が16．O
mcg／gと正常に比べ有意の減少がみられたが，
Honvanの影響は比較的軽度であった．背側部前立腺
ではSH 82100 mg群が21．8mcg／g， Honvan 10
mg群が30． 3 mcg／gで有意の減少がみられたが，
  ZiNC CONTENT Of TgE GENITAL ORGANS OF THE



















ZINC CONTEN丁 OF THE GENiTAL OR〔｝ANS OF THE RAτ
丁REAτED  Wtl「H PROGINON DEPOT   （Tncgle wet紺φ二〉ZINC ooNTENT OF THE GENITAL ORGANS OF THE pt1’













     Fig． 11
         0……正常（対照）群
         △……1．5mg群





























 2）処置（Honvan， S H 582投与）群検査材料
 材料はすべて当科に入院した前立腺癌患者から得て
亜鉛量を測定した．すなわちHonvanは第1週が250














ZINC CON丁ENT OF THE GENtTAL OR＆ANS OF THE RAT






    △・・…・50mg群×……100 mg群
Z燭CCONTE図τ OF 1甜E ＆［NiTAL ORGA艘S
OF T闘E POG τREAτεD  岡τH HON糊





Z捌CαDNTe屑T OF 11HE θモ欄11AL 〔沢6《NS OF THE 顧T
















    △・… 一Q．5mg群 x・・’… 1．5mg君1｛…
Z8梶C OONτE閥τ0「 1勤匪… 6E組ITAし OR6ANS
OF THE Dca TRUED wtra suse2
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                                  Table 15
  謬御難E轟、囎、陣   ZINC C…ENT・・TH…NI丁A…G・・・…T・・。。・
           （照臨噸）       TREATED WITH H。NVAN
                              ortgan Z in¢ content of QrgQn
                                     （mcg．／g．vvet weight）
                            Testls 8．91 81 ±1．7564
                            Caput epidldyrnis a 2．58a B±4．DqsO
                            Cauda ep ididymis 11 ．6555 t 2．3566
                            prostete ． nat re60rded
















          Table 14





























  Zlne content ot argan
〈rncg．／g．wet weight｝ （MCg．／ organ）
10．6000t 3．1 908 132．8142±43 ．” 776
nS．3857± 6．Ogol 19．s50Q± 6．s2r）s
As ．72sO ＋一 7 ．n 040 M A 666t 5．0677
33 ．s769 ± e ．4075 not recondgd







































































ZINC CONTENT OF ruE GENITAL ORaMS
OF 丁HE 醐  BEFORE AND AFTER  ．
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／g（Ta1〕le 16， Fig．21 motility 3．0の項），沈渣が












         Table’ 16
ZINC CONTE：NT OF SEMINAしPLASMA OF THE MAN
rUlotility of sperm
  （O 一 3＞




















1 66 ．3846tl Ol ．8208
M3．6364± 70．5463
1M．5pt 4± ” ．4740 ’
20u ．5000t 95 ．9926
（mean with standard deviation）
ZINC CONTENT OF 6EMINAL PLASMA
OF THE MAN AND MOTIUTY OF SPERM
mrlal level


























         Table 17
ZINC CONTENT OF SEMINAL SEDIMENT OF rHE MAN
。へ1
0 O．5 ke L5 ？．O 9s5
















  （O 一 3）
























200 ．・ 6364 ti 25 ，7626
228．4615M53．3807
1 85 ．0909± 95 ．4934
238．7143”3B．9899
266 ．2500M一 29．8397
（mean with standard deviation）
ZINC CON丁EN丁 OF SEMINAL SEDIM1…NT






















ZINC CON丁E：NT OF SEMINAL PLAsMA OF’「HE MAN
Count． of sperm
（x1 06／m1 ）









（mcg ．／g ．wet weight）




（mgan with standard deviatien）
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              Table 19











   25396857士174．4465
   239．0667±188．9S80
   1225 ．5556± 1 31 ．8321
（meari with standard deviatiort）
ZINC CO麗TENT OF S…≡剛捜AL SEDIMENT
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ZINC CONTENT OF SEMINAL PLASMA AND
   TOTAL URINARY GONADOTROPIN
Fig． 2tt．
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Table 20． ZINC CONTENT OF SEMINAL PLASMA， COUNT OF
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